Subject(s)
Arteries/diagnostic imaging , Giant Cell Arteritis/diagnostic imaging , Female , Humans , Male , Radionuclide ImagingABSTRACT
BACKGROUND: Positron emission tomography (PET) scan is emerging as a promising imaging technique to detect large-vessel inflammation in giant cell arteritis (GCA). However, the lack of a standardised definition of arteritis based on (18)fluorodeoxyglucose (FDG) uptake is an important limitation to the use of PET scan for diagnostic purposes. OBJECTIVE: To prospectively assess the intensity and distribution of FDG uptake at different vascular territories in patients with newly diagnosed GCA compared with controls. METHODS: 32 consecutive, biopsy-proven, GCA patients treated with glucocorticoids for ≤3 days were included. The control group consisted of 20 individuals, who underwent PET/CT for cancer staging. Maximal standardised uptake value (SUVm) was calculated at four aortic segments, supraaortic branches and iliac-femoral territory. Sensitivity and specificity was calculated by receiver-operator characteristic curves (ROC) analysis. RESULTS: Mean SUVm was significantly higher in patients than in controls in all vessels explored and correlated with acute-phase reactants and serum IL-6. Mean of the SUVm at all the vascular territories had an area under the curve (AUC) of 0.830, and a cut-off of 1.89 yielded a sensitivity of 80% and a specificity of 79% for GCA diagnosis. There were no significant differences in AUC among the vascular beds examined. CONCLUSIONS: FDG uptake by large vessels has a substantial sensitivity and specificity for GCA diagnosis.
Subject(s)
Arteries/diagnostic imaging , Giant Cell Arteritis/diagnostic imaging , Acute-Phase Proteins/immunology , Aged , Aged, 80 and over , Aorta/diagnostic imaging , Area Under Curve , Arteries/pathology , Axillary Artery/diagnostic imaging , Biopsy , Carotid Arteries/diagnostic imaging , Case-Control Studies , Female , Femoral Artery/diagnostic imaging , Fluorodeoxyglucose F18 , Giant Cell Arteritis/immunology , Giant Cell Arteritis/pathology , Humans , Iliac Artery/diagnostic imaging , Interleukin-6/immunology , Male , Middle Aged , Multimodal Imaging , Positron-Emission Tomography , Prospective Studies , ROC Curve , Radiopharmaceuticals , Sensitivity and Specificity , Subclavian Artery/diagnostic imaging , Temporal Arteries/pathology , Tomography, X-Ray ComputedABSTRACT
PURPOSE: The aim of the study was to determine if pinhole collimator-acquired images can improve the detection of hyperfunctioning parathyroid glands in patients with secondary hyperparathyroidism. METHODS: Forty-two patients being treated with cinacalcet for secondary hyperparathyroidism were studied prospectively. Patients were divided into 2 groups according to their levels of parathyroid hormone (PTH), the hormone that defines response to treatment: "responders" (PTH <300 pg/mL) and "nonresponders" (PTH ≥ 300 pg/mL). Double-phase scintigraphy using 888 MBq of (99m)Tc-MIBI was used to acquire early and late parallel-hole and pinhole collimator images. Neck ultrasonography was performed on all patients to identify intrathyroid nodules. All focal uptake in any of the acquired scintigraphic images was considered positive. RESULTS: The responder group included 24 patients, whereas 18 patients were considered as nonresponders. At least 1 parathyroid gland with (99m)Tc-MIBI uptake was detected in 33 of 42 patients, with a total of 50 parathyroid glands located. We found significant differences between the detection rates of late pinhole collimator and the late parallel-hole images (74% vs 48%, P = 0.0036). This detection rate was highest with late parallel-hole images in the nonresponder group (89%). CONCLUSIONS: The late pinhole collimator acquisition showed the highest detection rate of hyperfunctioning parathyroid glands using (99m)Tc-MIBI scintigraphy in secondary hyperparathyroidism patients treated with cinacalcet.
